Non Small Cell Lung Cancer Treatment - Global and China Top Players Market Share and Ranking 2024
- Report Code : AMP2755928
- Published On: Jul, 2024
- Category : Healthcare & Pharma
- Pages : 130
-
According to Ample Market Research, the global market for Non Small Cell Lung Cancer Treatment should grow from US$ 132 million in 2022 to US$ 260.9 million by 2029, with a CAGR of 9.3% for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Non Small Cell Lung Cancer Treatment market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Non Small Cell Lung Cancer Treatment market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
This report studies and analyses global Non Small Cell Lung Cancer Treatment status and future trends, to help determine the Non Small Cell Lung Cancer Treatment market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Non Small Cell Lung Cancer Treatment, and provides market size (US$ million) and Year-over-Year growth, considering 2024 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Non Small Cell Lung Cancer Treatment market size, history data 2019-2024, and forecast data 2024-2030, (US$ million)
(2) Global Non Small Cell Lung Cancer Treatment by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(3) China Non Small Cell Lung Cancer Treatment by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(4) Global Non Small Cell Lung Cancer Treatment key consuming regions, consumption value and demand structure
(5) Non Small Cell Lung Cancer Treatment industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Novartis AG
Pfizer Inc
Sanofi
F. Hoffmann-La Roche Ltd
Astrazeneca
Eli Lilly and Company
Merck & Co Inc
Bristol-Myers Squibb Company
Celgene Corporation
Market segment by Type, covers
Chemotherapy
Targeted Therapy
Immunotherapy
Market segment by Application, can be divided into
Hospital
Clinic
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Non Small Cell Lung Cancer Treatment product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Non Small Cell Lung Cancer Treatment market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 3: China Non Small Cell Lung Cancer Treatment market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 4: Non Small Cell Lung Cancer Treatment industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2019-2030
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2019-2030
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2019-2030
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2019-2030
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide Non Small Cell Lung Cancer Treatment Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Non Small Cell Lung Cancer Treatment Definition
1.2 Global Non Small Cell Lung Cancer Treatment Market Size and Forecast
1.3 China Non Small Cell Lung Cancer Treatment Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Non Small Cell Lung Cancer Treatment Market Size: China VS Global Growth Rate, 2019-2030
1.6 Non Small Cell Lung Cancer Treatment Market Dynamics
1.6.1 Non Small Cell Lung Cancer Treatment Market Drivers
1.6.2 Non Small Cell Lung Cancer Treatment Market Restraints
1.6.3 Non Small Cell Lung Cancer Treatment Industry Trends
1.6.4 Non Small Cell Lung Cancer Treatment Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of Non Small Cell Lung Cancer Treatment, Global Market Share by Company, 2019-2024
2.2 Global Non Small Cell Lung Cancer Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Non Small Cell Lung Cancer Treatment Concentration Ratio
2.4 Global Non Small Cell Lung Cancer Treatment Mergers & Acquisitions, Expansion Plans
2.5 Global Non Small Cell Lung Cancer Treatment Major Companies Product Type
2.6 Head Office and Non Small Cell Lung Cancer Treatment Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of Non Small Cell Lung Cancer Treatment, China Market Share by Company, 2019-2024
3.2 China Non Small Cell Lung Cancer Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 Non Small Cell Lung Cancer Treatment Industry Chain
4.2 Non Small Cell Lung Cancer Treatment Upstream Analysis
4.2.1 Non Small Cell Lung Cancer Treatment Core Raw Materials
4.2.2 Main Manufacturers of Non Small Cell Lung Cancer Treatment Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Non Small Cell Lung Cancer Treatment Production Mode
4.6 Non Small Cell Lung Cancer Treatment Procurement Model
4.7 Non Small Cell Lung Cancer Treatment Industry Sales Model and Sales Channels
4.7.1 Non Small Cell Lung Cancer Treatment Sales Model
4.7.2 Non Small Cell Lung Cancer Treatment Typical Distributors
5 Sights by Type5.1 Non Small Cell Lung Cancer Treatment Classification
5.1.1 Chemotherapy
5.1.2 Targeted Therapy
5.1.3 Immunotherapy5.2 By Type, Global Non Small Cell Lung Cancer Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030
5.3 By Type, Global Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030
6 Sights by Application6.1 Non Small Cell Lung Cancer Treatment Segment by Application
6.1.1 Hospital
6.1.2 Clinic
6.1.3 Others6.2 By Application, Global Non Small Cell Lung Cancer Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Application, Global Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030
7 Sales Sights by Region7.1 By Region, Global Non Small Cell Lung Cancer Treatment Consumption Value, 2019 VS 2024 VS 2030
7.2 By Region, Global Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030
7.3 North America
7.3.1 North America Non Small Cell Lung Cancer Treatment & Forecasts, 2019-2030
7.3.2 By Country, North America Non Small Cell Lung Cancer Treatment Market Size Market Share7.4 Europe
7.4.1 Europe Non Small Cell Lung Cancer Treatment Market Size & Forecasts, 2019-2030
7.4.2 By Country, Europe Non Small Cell Lung Cancer Treatment Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific Non Small Cell Lung Cancer Treatment Market Size & Forecasts, 2019-2030
7.5.2 By Country/Region, Asia Pacific Non Small Cell Lung Cancer Treatment Market Size Market Share7.6 South America
7.6.1 South America Non Small Cell Lung Cancer Treatment Market Size & Forecasts, 2019-2030
7.6.2 By Country, South America Non Small Cell Lung Cancer Treatment Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global Non Small Cell Lung Cancer Treatment Market Size & CAGR, 2019 VS 2024 VS 2030
8.2 By Country, Global Non Small Cell Lung Cancer Treatment Consumption Value, 2019-2030
8.3 U.S.
8.3.1 U.S. Non Small Cell Lung Cancer Treatment Market Size, 2019-2030
8.3.2 By Type, U.S. Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 2030
8.3.3 By Application, U.S. Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 20308.4 Europe
8.4.1 Europe Non Small Cell Lung Cancer Treatment Market Size, 2019-2030
8.4.2 By Type, Europe Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 2030
8.4.3 By Application, Europe Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 20308.5 China
8.5.1 China Non Small Cell Lung Cancer Treatment Market Size, 2019-2030
8.5.2 By Type, China Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 2030
8.5.3 By Application, China Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 20308.6 Japan
8.6.1 Japan Non Small Cell Lung Cancer Treatment Market Size, 2019-2030
8.6.2 By Type, Japan Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 2030
8.6.3 By Application, Japan Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 2030
8.7 South Korea
8.7.1 South Korea Non Small Cell Lung Cancer Treatment Market Size, 2019-2030
8.7.2 By Type, South Korea Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 2030
8.7.3 By Application, South Korea Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 2030
8.8 Southeast Asia
8.8.1 Southeast Asia Non Small Cell Lung Cancer Treatment Market Size, 2019-2030
8.8.2 By Type, Southeast Asia Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 2030
8.8.3 By Application, Southeast Asia Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 2030
8.9 India
8.9.1 India Non Small Cell Lung Cancer Treatment Market Size, 2019-2030
8.9.2 By Type, India Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 2030
8.9.3 By Application, India Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 20308.10 Middle East & Africa
8.10.1 Middle East & Africa Non Small Cell Lung Cancer Treatment Market Size, 2019-2030
8.10.2 By Type, Middle East & Africa Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 2030
8.10.3 By Application, Middle East & Africa Non Small Cell Lung Cancer Treatment Consumption Value Market Share, 2024 VS 2030
9 Company Profile9.1 Novartis AG
9.1.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
9.1.2 Novartis AG Company Profile and Main Business
9.1.3 Novartis AG Non Small Cell Lung Cancer Treatment Models, Specifications and Application
9.1.4 Novartis AG Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024
9.1.5 Novartis AG Recent Developments9.2 Pfizer Inc
9.2.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position
9.2.2 Pfizer Inc Company Profile and Main Business
9.2.3 Pfizer Inc Non Small Cell Lung Cancer Treatment Models, Specifications and Application
9.2.4 Pfizer Inc Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024
9.2.5 Pfizer Inc Recent Developments9.3 Sanofi
9.3.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.3.2 Sanofi Company Profile and Main Business
9.3.3 Sanofi Non Small Cell Lung Cancer Treatment Models, Specifications and Application
9.3.4 Sanofi Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024
9.3.5 Sanofi Recent Developments9.4 F. Hoffmann-La Roche Ltd
9.4.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
9.4.2 F. Hoffmann-La Roche Ltd Company Profile and Main Business
9.4.3 F. Hoffmann-La Roche Ltd Non Small Cell Lung Cancer Treatment Models, Specifications and Application
9.4.4 F. Hoffmann-La Roche Ltd Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024
9.4.5 F. Hoffmann-La Roche Ltd Recent Developments9.5 Astrazeneca
9.5.1 Astrazeneca Company Information, Head Office, Market Area and Industry Position
9.5.2 Astrazeneca Company Profile and Main Business
9.5.3 Astrazeneca Non Small Cell Lung Cancer Treatment Models, Specifications and Application
9.5.4 Astrazeneca Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024
9.5.5 Astrazeneca Recent Developments9.6 Eli Lilly and Company
9.6.1 Eli Lilly and Company Company Information, Head Office, Market Area and Industry Position
9.6.2 Eli Lilly and Company Company Profile and Main Business
9.6.3 Eli Lilly and Company Non Small Cell Lung Cancer Treatment Models, Specifications and Application
9.6.4 Eli Lilly and Company Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024
9.6.5 Eli Lilly and Company Recent Developments
9.7 Merck & Co Inc
9.7.1 Merck & Co Inc Company Information, Head Office, Market Area and Industry Position
9.7.2 Merck & Co Inc Company Profile and Main Business
9.7.3 Merck & Co Inc Non Small Cell Lung Cancer Treatment Models, Specifications and Application
9.7.4 Merck & Co Inc Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024
9.7.5 Merck & Co Inc Recent Developments
9.8 Bristol-Myers Squibb Company
9.8.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
9.8.2 Bristol-Myers Squibb Company Company Profile and Main Business
9.8.3 Bristol-Myers Squibb Company Non Small Cell Lung Cancer Treatment Models, Specifications and Application
9.8.4 Bristol-Myers Squibb Company Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024
9.8.5 Bristol-Myers Squibb Company Recent Developments
9.9 Celgene Corporation
9.9.1 Celgene Corporation Company Information, Head Office, Market Area and Industry Position
9.9.2 Celgene Corporation Company Profile and Main Business
9.9.3 Celgene Corporation Non Small Cell Lung Cancer Treatment Models, Specifications and Application
9.9.4 Celgene Corporation Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024
9.9.5 Celgene Corporation Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The Non Small Cell Lung Cancer Treatment Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Non Small Cell Lung Cancer Treatment Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
The Non Small Cell Lung Cancer Treatment Global and China Top Players Market is expected to reach a reasonable valuation by 2029; now the market is expected to shift its focus from growth to value.
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Non Small Cell Lung Cancer Treatment Global and China Top Players Market across the extensive corporate landscape.
During the forecast years, the Non Small Cell Lung Cancer Treatment Global and China Top Players Market can thrive with a robust CAGR.
